HUM vs UTHR · P/E 39, rev $117.76B vs P/E 20, rev $2.88B
Humana Inc (HUM) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the HUM and UTHR stock pages for the full models.
Not investment advice.